We are live on ! Find out more
ZOM

Zomedica Corp.

Delisted

ZOM was delisted on the 4th of March, 2025.

9 hedge funds and large institutions have $141K invested in Zomedica Corp. in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% less funds holding

Funds holding: 109 (-1)

33% less capital invested

Capital invested by funds: $209K → $141K (-$68.7K)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ZOM Hedge Fund Activity: Q3 2025 in Review

9 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2025, worth a combined $141K — down 33% from $209K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ZOM and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.

The largest buyer was Jackson Wealth Management, opening a new position worth an estimated $50K. The largest seller was Ancora Advisors, cutting an estimated $302K.

  • 9 institutional investors held Zomedica Corp. (ZOM) as of Q3 2025, down from 10 in Q2 2025.
  • Funds reported $141K of Zomedica Corp. stock for Q3 2025, down 33% quarter-over-quarter.
  • 2 funds opened new Zomedica Corp. positions in Q3 2025 and 3 closed out, a net change of -1 holder.
  • The largest Zomedica Corp. buyer in Q3 2025 was Jackson Wealth Management, an estimated $50K added.
  • The largest Zomedica Corp. seller in Q3 2025 was Ancora Advisors, an estimated $302K sold.

Based on aggregated 13F filings for Q3 2025.